These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 29059494)

  • 1. Molecular-based diagnosis of multiple sclerosis and its progressive stage.
    Barbour C; Kosa P; Komori M; Tanigawa M; Masvekar R; Wu T; Johnson K; Douvaras P; Fossati V; Herbst R; Wang Y; Tan K; Greenwood M; Bielekova B
    Ann Neurol; 2017 Nov; 82(5):795-812. PubMed ID: 29059494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis.
    Komori M; Blake A; Greenwood M; Lin YC; Kosa P; Ghazali D; Winokur P; Natrajan M; Wuest SC; Romm E; Panackal AA; Williamson PR; Wu T; Bielekova B
    Ann Neurol; 2015 Jul; 78(1):3-20. PubMed ID: 25808056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic pattern analysis discriminates among multiple sclerosis-related disorders.
    Komori M; Matsuyama Y; Nirasawa T; Thiele H; Becker M; Alexandrov T; Saida T; Tanaka M; Matsuo H; Tomimoto H; Takahashi R; Tashiro K; Ikegawa M; Kondo T
    Ann Neurol; 2012 May; 71(5):614-23. PubMed ID: 22522477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
    Stilund M; Gjelstrup MC; Petersen T; Møller HJ; Rasmussen PV; Christensen T
    PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis.
    Avsar T; Korkmaz D; Tütüncü M; Demirci NO; Saip S; Kamasak M; Siva A; Turanli ET
    Mult Scler; 2012 Aug; 18(8):1081-91. PubMed ID: 22252467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid interleukin-6 in central nervous system inflammatory diseases.
    Wullschleger A; Kapina V; Molnarfi N; Courvoisier DS; Seebach JD; Santiago-Raber ML; Hochstrasser DF; Lalive PH
    PLoS One; 2013; 8(8):e72399. PubMed ID: 24015240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry.
    Teunissen CE; Koel-Simmelink MJ; Pham TV; Knol JC; Khalil M; Trentini A; Killestein J; Nielsen J; Vrenken H; Popescu V; Dijkstra CD; Jimenez CR
    Mult Scler; 2011 Jul; 17(7):838-50. PubMed ID: 21505015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human kallikrein 6 cerebrospinal levels are elevated in multiple sclerosis.
    Hebb AL; Bhan V; Wishart AD; Moore CS; Robertson GS
    Curr Drug Discov Technol; 2010 Jun; 7(2):137-40. PubMed ID: 20836755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid growth-associated protein 43 in multiple sclerosis.
    Sandelius Å; Sandgren S; Axelsson M; Malmeström C; Novakova L; Kostanjevecki V; Vandijck M; Blennow K; Zetterberg H; Lycke J
    Sci Rep; 2019 Nov; 9(1):17309. PubMed ID: 31754174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and cerebrospinal fluid nitrite and nitrate levels in relapsing-remitting and secondary progressive multiple sclerosis patients.
    Yuceyar N; Taşkiran D; Sağduyu A
    Clin Neurol Neurosurg; 2001 Dec; 103(4):206-11. PubMed ID: 11714562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers.
    Ottervald J; Franzén B; Nilsson K; Andersson LI; Khademi M; Eriksson B; Kjellström S; Marko-Varga G; Végvári A; Harris RA; Laurell T; Miliotis T; Matusevicius D; Salter H; Ferm M; Olsson T
    J Proteomics; 2010 Apr; 73(6):1117-32. PubMed ID: 20093204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau protein level in cerebrospinal fluid is increased in patients with early multiple sclerosis.
    Brettschneider J; Maier M; Arda S; Claus A; Süssmuth SD; Kassubek J; Tumani H
    Mult Scler; 2005 Jun; 11(3):261-5. PubMed ID: 15957504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid sulfatide isoforms lack diagnostic utility in separating progressive from relapsing-remitting multiple sclerosis.
    Novakova L; Henricsson M; Björnson E; Axelsson M; Borén J; Rosenstein I; Lycke J; Cardell SL; Blomqvist M
    Mult Scler Relat Disord; 2023 Jun; 74():104705. PubMed ID: 37060853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system.
    Jongen PJ; Doesburg WH; Ibrahim-Stappers JL; Lemmens WA; Hommes OR; Lamers KJ
    Acta Neurol Scand; 2000 Feb; 101(2):116-21. PubMed ID: 10685859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis.
    Kuhle J; Leppert D; Petzold A; Regeniter A; Schindler C; Mehling M; Anthony DC; Kappos L; Lindberg RL
    Neurology; 2011 Apr; 76(14):1206-13. PubMed ID: 21346223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF Levels of CXCL12 and Osteopontin as Early Markers of Primary Progressive Multiple Sclerosis.
    Marastoni D; Magliozzi R; Bolzan A; Pisani AI; Rossi S; Crescenzo F; Montemezzi S; Pizzini FB; Calabrese M
    Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34588298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study.
    Haghikia A; Haghikia A; Hellwig K; Baraniskin A; Holzmann A; Décard BF; Thum T; Gold R
    Neurology; 2012 Nov; 79(22):2166-70. PubMed ID: 23077021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid mtDNA concentration is elevated in multiple sclerosis disease and responds to treatment.
    Leurs CE; Podlesniy P; Trullas R; Balk L; Steenwijk MD; Malekzadeh A; Piehl F; Uitdehaag BM; Killestein J; van Horssen J; Teunissen CE
    Mult Scler; 2018 Apr; 24(4):472-480. PubMed ID: 28294696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls.
    Kroksveen AC; Guldbrandsen A; Vedeler C; Myhr KM; Opsahl JA; Berven FS
    Acta Neurol Scand Suppl; 2012; (195):90-6. PubMed ID: 23278663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis.
    Iwanowski P; Losy J; Kramer L; Wójcicka M; Kaufman E
    J Neurol Sci; 2017 Sep; 380():22-26. PubMed ID: 28870573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.